Mersana Therapeutics, Inc. Gains 69.05%
Wed, May 27, 2020 at 05:30 PM
Mersana Therapeutics, Inc. (MRSN:NASDAQ) jumped higher at $18.19, representing a gain of 69.1%. On Tue 26 May 20, MRSN:NASDAQ touched a New 2-Week High of $10.76. The stock got featured on our News Catalysts scanner on Wed 27 May 20 at 09:34 AM in the 'BIOTECH' category. From Tue 12 May 20, the stock recorded 55.56% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Mersana Therapeutics, Inc. (MRSN:NASDAQ)
Mersana Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
Top 10 Gainers:
- Hertz Global Holdings, Inc. (HTZ:NYSE), 136.04%
- LSAC (LSAC:NASDAQ), 100%
- Ascena Retail Group, Inc. (ASNA:NASDAQ), 73.61%
- Mersana Therapeutics, Inc. (MRSN:NASDAQ), 69.05%
- 36Kr Holdings Inc. (KRKR:NASDAQ), 51.11%
- Town Sports International Holdings, Inc. (CLUB:NASDAQ), 46.13%
- RealNetworks, Inc. (RNWK:NASDAQ), 44.17%
- Euroseas Ltd. (ESEA:NASDAQ), 39.92%
- NantKwest, Inc. (NK:NASDAQ), 39.08%
- Nam Tai Property Inc. (NTP:NYSE), 34.32%